1400.9000 2.70 (0.19%)
NSE Nov 19, 2026 15:31 PM
Volume: 1.5M
 

1400.90
0.19%
Emkay
Dr Reddy's has disclosed that it has halted commercial supplies of Semaglutide with the recently scaled-up batch being found to be out of specification due to an issue associated with an impurity.
Dr. Reddy's Laborato.. has an average target of 1335.44 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended